Loading interface...

Juniz Rds 2.5 mg Suppository

Manufactured byElder Pharmaceuticals Ltd.
ContainsDiazepam
Description

Juniz Rds 2.5 mg Suppository is an anticonvulsant medicine, which may be used for the treatment of febrile convulsion and convulsive seizure of epilepsy. This medicine should be used with extreme caution since it has a high potential for addiction and abuse even at recommended dosages, especially with prolonged use.

Side effects

Major & minor side effects for Juniz Rds 2.5 mg Suppository

  • Constipation
  • Indigestion
  • Itching or rash
  • Unsteady walk
  • Diarrhea

Uses of Juniz Rds 2.5 mg Suppository

What is it prescribed for?

  • Epilepsy (Seizures)
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of side effects such as difficulty concentrating and dizziness. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
  • Is this a habit forming medicine?
    Habit-forming tendencies were reported in some cases especially if the usage is for an extended period of time. A gradual withdrawal of the drug i.e. decrease in dosing over a period of time is suggested in such cases.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine. If the medicine is used, the infant should be monitored closely for any adverse effects.

Allergy

This medicine is not recommended for use in patients with a known allergy to diazepam, or any other inactive ingredients present in the formulation.

Myasthenia gravis

This medicine is not recommended for use in patients with myasthenia gravis due to the increased risk of serious adverse effects.

Narrow-angle glaucoma

This medicine is not recommended for use in patients with narrow-angle glaucoma since it may worsen the patient's condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine. If the medicine is used, the infant should be monitored closely for any adverse effects.
General warnings

Suicidal thoughts

This medicine may cause suicidal behavior in some patients. This risk is especially higher on the prolonged usage of the medicine. Patients should be monitored closely for any changes in behavior and mood; any such changes should be reported to the doctor immediately. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Withdrawal symptoms

Abrupt discontinuation of this medicine may increase the risk of severe adverse effects, especially if you have been using a high dose for a long duration. A gradual dose reduction is recommended to avoid these reactions. Do not stop the use of this medicine without consulting your doctor.

Drug dependence

This medicine has the potential to cause drug dependence and abuse. This risk is especially higher if the medicine is used for a prolonged period of time. Patients should be monitored closely for any change in mood and behavior during treatment with this medicine. Abrupt discontinuation is not recommended since it may cause withdrawal symptoms. Withdrawal of therapy should be done gradually with close monitoring.

Concomitant use of opioids

Coadministration of diazepam and opioids like morphine, codeine, tramadol, hydrocodone, or any cough preparations containing these medicines should be avoided since it may increase the risk of sedation, breathlessness, coma, and death. Appropriate dose adjustments are to be made if coadministration is needed and monitoring of sedation, breathlessness, and hypotension is necessary.

Missed Dose

Administer the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose.

Overdose

Seek emergency medical attention or contact your doctor if an overdose with this medicine is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of side effects such as difficulty concentrating and dizziness. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.
Interaction with Medicine

Cetirizine

Metoclopramide

Opioids

Azole antifungal agents

Atenolol

Disease interactions

Closed-Angle Glaucoma

This medicine is not recommended for use in patients with a known history of closed-angle glaucoma due to the increased risk of worsening of the patient's condition. Replacement with a suitable alternative should be considered under your doctor's supervision.

Impaired kidney function

This medicine should be used with caution in patients with kidney impairment due to an increased risk of worsening of the patient's condition. Close monitoring of kidney function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Impaired liver function

This medicine should be used with caution in patients with liver impairment due to an increased risk of worsening of the patient's condition. Close monitoring of the liver function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Depression

This medicine should be used with caution in patients suffering from depression and other psychiatric disorders due to the increased risk of suicidal thoughts, especially at the beginning of the treatment and at the time of dose change. Patients should be monitored closely for any change in behavior and mood. Replacement with a suitable alternative may be required in some cases based on the clinical condition.
Food interactions
Consumption of grapefruit juice is not recommended during treatment with this medicine due to the increased risk of severe adverse effects.
Lab interactions
Information not available.
Use this medicine as advised by your doctor. Do not use in larger amounts than advised. Consult the doctor if you experience any undesirable side effects. Follow all the instructions given in the patient information leaflet. Your dose is likely to be changed by the doctor during the course of treatment and hence all changes should be properly followed. The usage should be stopped gradually over time as instructed.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Causes sleepiness

How it works
This medicine works by binding to certain chemicals in the brain and helps in relieving the symptoms.
Legal Status

Approved

Unknown

Approved

Unknown

Classification

Category

Benzodiazepines

Schedule

Schedule H

Diazepam - DrugBank [Internet]. Drugbank.ca. 2020 [cited 11 March 2020]. Available from:

https://www.drugbank.ca/drugs/DB00829

Diazepam [Internet]. Pubchem.ncbi.nlm.nih.gov. 2020 [cited 11 March 2020]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/Diazepam

Search results detail| Kusurino-Shiori(Drug information Sheet) [Internet]. Rad-ar.or.jp. 2020 [cited 21 May 2020]. Available from:

http://www.rad-ar.or.jp/siori/english/kekka.cgi?n=42027
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 21 May 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.